CLDI
CLDI
AMEX · Biotechnology

Calidi Biotherapeutics Inc

$0.24
-0.03 (-11.67%)
As of Mar 30, 10:13 PM ET ·
Financial Highlights (FY 2025)
Revenue
1.75M
Net Income
-488,923
Gross Margin
32.9%
Profit Margin
-27.9%
Rev Growth
+4.0%
D/E Ratio
0.91
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 32.9% 32.9% 32.9%
Operating Margin -31.7% -34.4% -32.2%
Profit Margin -27.9% -29.7% -33.3%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.75M 1.85M 1.56M
Gross Profit 575.6K 607.8K 512.8K
Operating Income -554,961 -636,052 -502,281
Net Income -488,923 -548,272 -518,591
Gross Margin 32.9% 32.9% 32.9%
Operating Margin -31.7% -34.4% -32.2%
Profit Margin -27.9% -29.7% -33.3%
Rev Growth +4.0% +6.5% +13.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.36M 2.38M 2.23M
Total Equity 2.58M 2.45M 2.67M
D/E Ratio 0.91 0.97 0.83
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -843,788 -899,520 -655,593
Free Cash Flow -343,922 -223,177 -234,743